23/08/2021
Arab Times
Share:
KUWAIT CITY, Aug 23, (Agencies): Kuwait’s pharmaceutical regulator on Monday granted emergency use approval for an artificial antibody drug known as ‘Ronapreve’ to treat COVID-19, the health ministry said. The antibody drug, developed by the US biotech company Regeneron, has been approved by the Medicines and Healthcare products Regulatory Agency; UK’s drug regulator, said the ministry’s Assistant Undersecretary for drug control Dr. Abdullah Al-Bader. The drug has been shown to be effective in reducing the likelihood of COVID-induced hospitalizations, added the official, hailing the medication as a useful tool to ease the strain on hospitals.
